Henry Schein Medical Announces Expansion of Medpod’s Telemedicine Solutions With Integration of VisualDx

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

July 9, 2020

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. and exclusive distributor of Medpod, Inc.’s telemedicine solutions, announced today the integration of VisualDx – a clinical decision support system – with Medpod’s technology infrastructure to help health care professionals better diagnose patients virtually.

Henry Schein notes VisualDx is designed to enhance diagnostic accuracy, aid therapeutic decisions, and improve patient care, all critically important to health care professionals on the front lines of medicine.

“Henry Schein Medical is pleased to announce the expansion and enhancement of the Medpod platform for our customers. With many clinicians moving to a virtual care model, it’s imperative that they are equipped with decision-support technology to aid in diagnostic and therapeutic decisions,” said Todd Stack, Senior Director, Henry Schein Medical, who manages the exclusive relationship with Medpod. “With Medpod, our customers can engage with patients remotely to reduce exposure, and monitor at risk and symptomatic patients remotely, which benefits both the patient and practice.”

Medpod’s cloud-based software and modular infrastructure gives providers and operators the ability to deliver customizable, high-quality, and convenient care that meets the needs of patients who cannot visit a traditional office setting. With the integration of VisualDx’s clinical support, Medpod users can access a database of information written by a variety of medical experts; recognize disease variants; identify drug adverse events; and enhance patient education to help provide informed, accurate, and fast decision-making. The platform also assists users to make custom diagnoses as a result of having the ability to enter patient-specific information, such as age range, gender, symptoms and signs; search by disease for quick therapy and treatment options; review and compare a curated medical image library; enhance understanding of medication reactions; and share patient handouts via email. Clinicians can also earn Continuing Medical Education (CME) credits each time they use VisualDx as part of their subscription.

Available as one of Henry Schein Medical’s SolutionHub™ clinical support solutions, VisualDx can support common and complex diagnostic cases across medicine including rashes, variant presentations of symptoms, and emerging infectious diseases. The software is relevant for a range of health care specialties, including: Family Medicine, Internal Medicine, Urgent Care, Infectious Disease, Dermatology, Emergency Medicine, Pediatrics, Risk Management, and Medical Education.

“We are excited to continue to enhance our relationship with Henry Schein by offering this telemedicine integration to help aid clinician decisions, drive quality care, and enhance diagnostic and therapy decisions during the telemedicine encounter,” said Art Papier, MD, CEO of VisualDx.

spot_img

DON'T MISS

Related Articles